When investors are paying such high price tags for a stock, expectations are high, and any kind of miss can result in a steep ...
"Given the fact that there are states, counties, cities, school districts, pension funds, and other plaintiffs from all over ...
FOIA requests to the federal government often are signals. They can be an important early warning of bad publicity, litigation to come, or uncertainties to be hedged and gamed out. When the flow of ...
Diabetes mellitus is a metabolic disease that causes high blood sugar. Your body either doesn’t make enough insulin or can’t effectively use the insulin it makes. The hormone insulin moves ...
Eli Lilly markets tirzepatide through two brand names: Mounjaro and Zepbound. The former has been approved by the FDA to combat type 2 diabetes, while the latter is used for weight loss.
It said that may be at odds with the FDA's view. Insurers generally cover Lilly's and Novo's drugs for diabetes, but many do not cover the weight-loss medications. That has led many patients to ...
Mumbai: Global pharma major Lupin Limited has announced the acquisition of Huminsulin in India from Eli Lilly and Company to further enhance its diabetes portfolio. Lupin has been marketing the ...
Global pharma major Lupin Limited on Monday announced the acquisition of Huminsulin in India from Eli Lilly and Company (Lilly) to further enhance its diabetes portfolio. According to the company ...
Shares of Lupin hit a new high of Rs 2,361.95, gaining 2 per cent on the BSE in Tuesday’s intra-day trade in an otherwise weak market after the company said it has acquired Huminsulin in India from ...
Global pharma major Lupin Limited announced the acquisition of Huminsulin in India from Eli Lilly and Company (Lilly) to further enhance its diabetes portfolio. Lupin has been marketing the Huminsulin ...
Global pharmaceutical giant Lupin on Monday announced the acquisition of Huminsulin in India from Eli Lilly and Company. This move aims to significantly strengthen Lupin's existing diabetes portfolio.